Rtw Investments as of Sept. 30, 2017
Portfolio Holdings for Rtw Investments
Rtw Investments holds 27 positions in its portfolio as reported in the September 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Alnylam Pharmaceuticals (ALNY) | 12.8 | $73M | 623k | 117.49 | |
| Ptc Therapeutics I (PTCT) | 12.2 | $70M | 3.5M | 20.01 | |
| Bristol Myers Squibb (BMY) | 9.2 | $53M | 828k | 63.74 | |
| Regenxbio Inc equity us cm (RGNX) | 8.8 | $51M | 1.5M | 32.95 | |
| Avexis | 7.9 | $45M | 468k | 96.73 | |
| La Jolla Pharmaceuticl Com Par | 6.3 | $36M | 1.0M | 34.78 | |
| Achillion Pharmaceuticals | 6.1 | $35M | 7.8M | 4.49 | |
| Arbutus Biopharma (ABUS) | 5.7 | $33M | 5.3M | 6.20 | |
| Agenus (AGEN) | 3.2 | $19M | 4.2M | 4.41 | |
| Corium Intl | 3.2 | $19M | 1.7M | 11.08 | |
| BioCryst Pharmaceuticals (BCRX) | 3.0 | $17M | 3.3M | 5.24 | |
| Oxford Immunotec Global | 3.0 | $17M | 1.0M | 16.80 | |
| Bluebird Bio (BLUE) | 2.5 | $14M | 104k | 137.35 | |
| OraSure Technologies (OSUR) | 2.1 | $12M | 536k | 22.50 | |
| Dicerna Pharmaceuticals | 2.1 | $12M | 2.1M | 5.75 | |
| Myokardia | 1.9 | $11M | 254k | 42.85 | |
| Tactile Systems Technology, In (TCMD) | 1.9 | $11M | 353k | 30.95 | |
| Atara Biotherapeutics (ATRA) | 1.9 | $11M | 656k | 16.55 | |
| Masimo Corporation (MASI) | 1.8 | $11M | 121k | 86.56 | |
| Viveve Med | 1.3 | $7.7M | 1.5M | 5.24 | |
| Viewray (VRAYQ) | 1.0 | $5.9M | 1.0M | 5.76 | |
| Spring Bk Pharmaceuticals In | 0.7 | $4.2M | 249k | 16.84 | |
| Bovie Medical Corporation | 0.7 | $3.9M | 1.1M | 3.38 | |
| Zynerba Pharmaceuticals | 0.3 | $1.7M | 200k | 8.36 | |
| Global Blood Therapeutics In | 0.1 | $817k | 26k | 31.05 | |
| Argenx Se (ARGX) | 0.1 | $563k | 25k | 22.60 | |
| Sensus Healthcare Inc Wrt Exp | 0.0 | $90k | 155k | 0.58 |
